Back

Use of SGLT2 inhibitors and the incidence of urinary tract infections in patients with heart failure: a pooled analysis of four trials including 26,838 patients

29 June 2021 (08:00 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Antidiabetic Pharmacotherapy HFA Premium Access Heart Failure 2021

About the speaker

Photo
Doctor Josip Andjelo Borovac

University Hospital Centre Split, Split (Croatia)

738 More presentations in this session

Presentation thumbnail
Atrial lead insertion during cardiac implantable electronic devices implantation in patients with atrial arrhythmia on hospital admission, when does the struggle for sinus rhythm make sense?
Assistant Professor N. Radovanovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Features of the remodeling of atria and pulmonary veins in CHF patients with paroxysmal AF and permanent AF
Assistant Professor V. Kirillova (Ekaterinburg, RU)
Abstract Slides
Presentation thumbnail
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum
Doctor D. Moysidis (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of cardiac contractility modulation on ventricular rhythm and conduction disorders in patients with heart failure with reduced ejection fraction and various forms of atrial fibrillation
Doctor A. Safiullina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Was a difference between late and early new-onset of atrial fibrillation in non st-elevation myocardial infarction?
Doctor H. Santos (Lisboa, PT)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

Heart Failure 2021

29 June 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Effects of urinary tract infection and stopping sodium-glucose cotranspoter-2 inhibitors in patients with type 2 diabetes mellitus: a population-based study
26 April 2024
thumbnail
ESC Journals
66 Relative efficacy of sacubitril/valsartan, dapagliflozin and vericiguat: a systematic review and network meta-analysis
17 December 2020
thumbnail
Congress Presentation
SGLT2i uptake among heart failure patients with reduced ejection fraction: ongoing prescriber hesitancy and how to address this.
29 August 2022
thumbnail
Congress Presentation
Frequency and clinical impact of urinary tract infections in heart failure patients receiving SGLT-2 inhibitor therapy
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources